{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:28:48Z","timestamp":1786609728741,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01232-0","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:45:57Z","timestamp":1786607157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoinflammatory Syndromes of Hidradenitis Suppurativa: Updates in Clinical Features, Emerging Associations, and Management"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3641-3181","authenticated-orcid":false,"given":"Jade Y.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8562-462X","authenticated-orcid":false,"given":"Andrew L.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-849X","authenticated-orcid":false,"given":"Carlo Alberto","family":"Maronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-4169","authenticated-orcid":false,"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9710-8143","authenticated-orcid":false,"given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-4517","authenticated-orcid":false,"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-4917","authenticated-orcid":false,"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"publisher","unstructured":"van Straalen KR, Piguet V, Gudjonsson JE. Hidradenitis suppurativa: key insights into treatment success and failure. J Clin Invest. 134(21):e186744. https:\/\/doi.org\/10.1172\/JCI186744","DOI":"10.1172\/JCI186744"},{"issue":"10476","key":"1232_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","volume":"405","author":"R Sabat","year":"2025","unstructured":"Sabat R, Alavi A, Wolk K. Hidradenitis suppurativa. Lancet. 2025;405(10476):420\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(24)02475-9.","journal-title":"Lancet"},{"issue":"2","key":"1232_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clindermatol.2020.10.016","volume":"39","author":"S Garcovich","year":"2021","unstructured":"Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol. 2021;39(2):240\u20137. https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.016.","journal-title":"Clin Dermatol"},{"issue":"2","key":"1232_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.det.2023.12.004","volume":"42","author":"CA Maronese","year":"2024","unstructured":"Maronese CA, Moltrasio C, Marzano AV. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms. Dermatol Clin. 2024;42(2):247\u201365. https:\/\/doi.org\/10.1016\/j.det.2023.12.004.","journal-title":"Dermatol Clin"},{"issue":"4","key":"1232_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.clindermatol.2025.05.003","volume":"43","author":"ZB Mokos","year":"2025","unstructured":"Mokos ZB, Marinovi\u0107 B, Juki\u0107 IL, Buzina D\u0160, Vlahini\u0107 T, Mi\u0161e J. Hidradenitis suppurativa in autoinflammatory syndromes. Clin Dermatol. 2025;43(4):471\u20138. https:\/\/doi.org\/10.1016\/j.clindermatol.2025.05.003.","journal-title":"Clin Dermatol"},{"issue":"5","key":"1232_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/jvc2.70127","volume":"4","author":"L Acheampong","year":"2025","unstructured":"Acheampong L, Croitoru D, Joseph M, Alhusayen R, Brahimi N, Piguet V. Clinical Characteristics of a Canadian Cohort of Hidradenitis Suppurativa. JEADV Clin Pract. 2025;4(5):1234\u20138. https:\/\/doi.org\/10.1002\/jvc2.70127.","journal-title":"JEADV Clin Pract"},{"issue":"3","key":"1232_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","volume":"66","author":"M Braun-Falco","year":"2012","unstructured":"Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)\u2013a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66(3):409\u201315. https:\/\/doi.org\/10.1016\/j.jaad.2010.12.025.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1232_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","volume":"149","author":"AV Marzano","year":"2013","unstructured":"Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C, Pyogenic Arthritis. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa (PAPASH): A New Autoinflammatory Syndrome Associated With a Novel Mutation of the PSTPIP1 Gene. JAMA Dermatol. 2013;149(6):762\u20134. https:\/\/doi.org\/10.1001\/jamadermatol.2013.2907.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1232_CR9","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","volume":"72","author":"R Saraceno","year":"2015","unstructured":"Saraceno R, Babino G, Chiricozzi A, Zangrilli A, Chimenti S. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition. J Am Acad Dermatol. 2015;72(1):e42\u201344. https:\/\/doi.org\/10.1016\/j.jaad.2014.10.002.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1232_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","volume":"18","author":"V Bruzzese","year":"2012","unstructured":"Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor \u03b1 therapy. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2012;18(8):413\u20135. https:\/\/doi.org\/10.1097\/RHU.0b013e318278b84c.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"3","key":"1232_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.abd.2024.07.014","volume":"100","author":"LMO Salviano","year":"2025","unstructured":"Salviano LMO, Miyamoto D, Santi CG, Yendo TM, Rivitti-Machado MC. Pyoderma gangrenosum: a 22-year follow-up of patients in a tertiary reference hospital in Brazil. Bras Dermatol. 2025;100(3):462\u20139. https:\/\/doi.org\/10.1016\/j.abd.2024.07.014.","journal-title":"Bras Dermatol"},{"issue":"9","key":"1232_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.medcle.2024.11.014","volume":"164","author":"JP Velasco-Amador","year":"2025","unstructured":"Velasco-Amador JP, Moyano-Bueno D, Ruiz-Villaverde R. Pyoderma gangrenosum, acne and hidradenitis suppurativa (PASH syndrome) treated with dapsone monotherapy. Med Cl\u00ednica Engl Ed. 2025;164(9):508\u20139. https:\/\/doi.org\/10.1016\/j.medcle.2024.11.014.","journal-title":"Med Cl\u00ednica Engl Ed"},{"issue":"7","key":"1232_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00403-024-03125-7","volume":"316","author":"A Yan","year":"2024","unstructured":"Yan A, Gallardo M, Savu A, Kaffenberger B. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management. Arch Dermatol Res. 2024;316(7):397. https:\/\/doi.org\/10.1007\/s00403-024-03125-7.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"1232_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jvc2.52","volume":"1","author":"C Challamel","year":"2022","unstructured":"Challamel C, Girard C, Misery L. The efficacy of anti-IL-1 targeted therapy in PAPA and PASH syndrome. JEADV Clin Pract. 2022;1(3):275\u201380. https:\/\/doi.org\/10.1002\/jvc2.52.","journal-title":"JEADV Clin Pract"},{"issue":"1","key":"1232_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.abd.2020.08.034","volume":"97","author":"I Cawen","year":"2022","unstructured":"Cawen I, Navarrete J, Agorio C. PASH syndrome: a novel surgical approach. Bras Dermatol. 2022;97(1):121\u20133. https:\/\/doi.org\/10.1016\/j.abd.2020.08.034.","journal-title":"Bras Dermatol"},{"issue":"1","key":"1232_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ijd.17330","volume":"64","author":"H Feola","year":"2025","unstructured":"Feola H, Luna Cian R, Mancinelli MC, Cordoba LM, Crespi C. PASH syndrome: A novel MEFV mutation variant with excellent response to adalimumab in a refractory case. Int J Dermatol. 2025;64(1):183\u20135. https:\/\/doi.org\/10.1111\/ijd.17330.","journal-title":"Int J Dermatol"},{"issue":"11","key":"1232_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/DSS.0000000000003903","volume":"49","author":"A Yan","year":"2023","unstructured":"Yan A, Gallardo M, Milani-Nejad N, Kaffenberger B. Successful Management of Extensive Cribriform Facial Scarring Secondary to PASH Syndrome With a Combination of Medical and Surgical Treatments. Dermatol Surg. 2023;49(11):1049. https:\/\/doi.org\/10.1097\/DSS.0000000000003903.","journal-title":"Dermatol Surg"},{"issue":"11","key":"1232_CR18","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1111\/ijd.16766","volume":"62","author":"DA Marletta","year":"2023","unstructured":"Marletta DA, Barei F, Moltrasio C, Genovese G, Marzano AV. A case of PASH syndrome treated with guselkumab. Int J Dermatol. 2023;62(11):e585\u20137. https:\/\/doi.org\/10.1111\/ijd.16766.","journal-title":"Int J Dermatol"},{"key":"1232_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5114\/dr.2025.152307","volume":"112","author":"W Kruczek","year":"2025","unstructured":"Kruczek W, Pietrauszka K, Tekielak A, Bergler-Czop B. IL-36R Inhibitor \u2013 Spesolimab Highly Effective in the treatment of PASH Syndrome: Clinical Case with General Evidence Analysis. Dermatol Rev. 2025;112:38\u201346. https:\/\/doi.org\/10.5114\/dr.2025.152307.","journal-title":"Dermatol Rev"},{"issue":"6","key":"1232_CR20","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.12788\/cutis.0797","volume":"111","author":"G Brokamp","year":"2023","unstructured":"Brokamp G, Bechtel M, Chung C. Long-term Remission of Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome. Cutis. 2023;111(6):E2\u20136. https:\/\/doi.org\/10.12788\/cutis.0797.","journal-title":"Cutis"},{"issue":"4","key":"1232_CR21","first-page":"163","volume":"33","author":"D \u017divanovi\u0107","year":"2024","unstructured":"\u017divanovi\u0107 D, Demenj M, Nikoli\u0107 M. Hospitalized hidradenitis suppurativa patients at a university clinic: a fifteen-year retrospective analysis of hospitalized patients with a focus on sex differences. Acta Dermatovenerol Alp Pannonica Adriat. 2024;33(4):163\u20139.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"10","key":"1232_CR22","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1097\/MS9.0000000000002533","volume":"86","author":"N Abdul Rahman","year":"2024","unstructured":"Abdul Rahman N, Jazmati A, Roumi Jamal B, Darwish I, Kouja D, Ishkhanian S. A complex case of PASH syndrome: pyoderma gangrenosum, acne, suppurative hidradenitis, and Crohn\u2019s disease in a 36-year-old smoker. Ann Med Surg 2012. 2024;86(10):6280\u20134. https:\/\/doi.org\/10.1097\/MS9.0000000000002533.","journal-title":"Ann Med Surg 2012"},{"key":"1232_CR23","doi-asserted-by":"publisher","first-page":"856786","DOI":"10.3389\/fmed.2022.856786","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, Tsang LSL, Shi W, Li J. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review. Front Med. 2022;9:856786. https:\/\/doi.org\/10.3389\/fmed.2022.856786.","journal-title":"Front Med"},{"issue":"4","key":"1232_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14712\/18059694.2025.9","volume":"67","author":"S Kordeva","year":"2024","unstructured":"Kordeva S, Hristova A, Broshtilova V, Tchernev G. P(A)SH Syndrome: Case Presentation and Short Update of Related Disorders. Acta Medica (Hradec Kralove). 2024;67(4):125\u201332. https:\/\/doi.org\/10.14712\/18059694.2025.9.","journal-title":"Acta Medica (Hradec Kralove)"},{"issue":"5","key":"1232_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1159\/000521263","volume":"238","author":"AV Marzano","year":"2022","unstructured":"Marzano AV, Genovese G, Moltrasio C. Whole-Exome Sequencing in 10 Unrelated Patients with Syndromic Hidradenitis Suppurativa: A Preliminary Step for a Genotype-Phenotype Correlation. Dermatology. 2022;238(5):860\u20139. https:\/\/doi.org\/10.1159\/000521263.","journal-title":"Dermatology"},{"issue":"1","key":"1232_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/vaccines11010162","volume":"11","author":"C Moltrasio","year":"2023","unstructured":"Moltrasio C, Cagliani R, Sironi M. Autoinflammation in Syndromic Hidradenitis Suppurativa: The Role of AIM2. Vaccines. 2023;11(1):162. https:\/\/doi.org\/10.3390\/vaccines11010162.","journal-title":"Vaccines"},{"issue":"4","key":"1232_CR27","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3390\/ijms23042278","volume":"23","author":"LAC Brand\u00e3o","year":"2022","unstructured":"Brand\u00e3o LAC, de Moura RR, Marzano AV, Moltrasio C, Tricarico PM, Crovella S. Variant Enrichment Analysis to Explore Pathways Functionality in Complex Autoinflammatory Skin Disorders through Whole Exome Sequencing Analysis. Int J Mol Sci. 2022;23(4):2278. https:\/\/doi.org\/10.3390\/ijms23042278.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"1232_CR28","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.3390\/ijms251910374","volume":"25","author":"K Muret","year":"2024","unstructured":"Muret K, Le Goff V, Dandine-Roulland C. Comprehensive Catalog of Variants Potentially Associated with Hidradenitis Suppurativa, Including Newly Identified Variants from a Cohort of 100 Patients. Int J Mol Sci. 2024;25(19):10374. https:\/\/doi.org\/10.3390\/ijms251910374.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1232_CR29","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.xhgg.2023.100187","volume":"4","author":"DJ Morales-Heil","year":"2023","unstructured":"Morales-Heil DJ, Cao L, Sweeney C. Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa. HGG Adv. 2023;4(2):100187. https:\/\/doi.org\/10.1016\/j.xhgg.2023.100187.","journal-title":"HGG Adv"},{"key":"1232_CR30","doi-asserted-by":"publisher","first-page":"152277","DOI":"10.1016\/j.semarthrit.2023.152277","volume":"63","author":"C Matucci-Cerinic","year":"2023","unstructured":"Matucci-Cerinic C, Malattia C, Pistorio A. Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome. Semin Arthritis Rheum. 2023;63:152277. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152277.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1232_CR31","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1093\/rheumatology\/keaf065","volume":"64","author":"C Matucci-Cerinic","year":"2025","unstructured":"Matucci-Cerinic C, Attico A, Malattia C. Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study. Rheumatol Oxf Engl. 2025;64(6):3777\u201386. https:\/\/doi.org\/10.1093\/rheumatology\/keaf065.","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"1232_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.25251\/skin.8.3.12","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Bayefsky S, Coromilas A. Chronic Nonbacterial Osteomyelitis, Hidradenitis Suppurativa, and SAPHO Syndrome. SKIN J Cutan Med. 2024;8(3):1548\u201353. https:\/\/doi.org\/10.25251\/skin.8.3.12.","journal-title":"SKIN J Cutan Med"},{"issue":"7","key":"1232_CR33","doi-asserted-by":"publisher","first-page":"e15507","DOI":"10.1111\/dth.15507","volume":"35","author":"M Li","year":"2022","unstructured":"Li M, Xiang H, Liang Y. Secukinumab for PASS syndrome: A new choice for therapeutic challenge? Dermatol Ther. 2022;35(7):e15507. https:\/\/doi.org\/10.1111\/dth.15507.","journal-title":"Dermatol Ther"},{"issue":"3","key":"1232_CR34","doi-asserted-by":"publisher","first-page":"e15114","DOI":"10.1111\/1756-185X.15114","volume":"27","author":"G K\u0131rm\u0131z\u0131er","year":"2024","unstructured":"K\u0131rm\u0131z\u0131er G, K\u0131l\u0131n\u00e7 EA, Y\u0131ld\u0131r\u0131m NO, T\u00fcrsen \u00dc. Successful treatment of PASS syndrome with IVIG and anti-IL-1 treatment: A case report. Int J Rheum Dis. 2024;27(3):e15114. https:\/\/doi.org\/10.1111\/1756-185X.15114.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"1232_CR35","doi-asserted-by":"publisher","first-page":"7720064","DOI":"10.1155\/crrh\/7720064","volume":"2025","author":"IN Shevtsova","year":"2025","unstructured":"Shevtsova IN, Abbott JJ, Shevtsov PN, Bedoya GC, Norton DC. Secukinumab Leading to Rapid Improvement in Pyogenic Arthritis, Acne, Pyoderma Gangrenosum, and Hidradenitis Suppurativa (PAPASH) Syndrome: A Case Report and Review of Treatment Modalities for PAPASH Patients. Case Rep Rheumatol. 2025;2025(1):7720064. https:\/\/doi.org\/10.1155\/crrh\/7720064.","journal-title":"Case Rep Rheumatol"},{"issue":"4","key":"1232_CR36","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1111\/jdv.20308","volume":"39","author":"K Aw","year":"2025","unstructured":"Aw K, Chan HA, Sibbald C, Piguet V, Croitoru D. Familial Mediterranean fever and MEFV gene variants in hidradenitis suppurativa: A systematic review. J Eur Acad Dermatol Venereol. 2025;39(4):e329\u201332. https:\/\/doi.org\/10.1111\/jdv.20308.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1232_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/ced\/llac023","volume":"48","author":"A Oktem","year":"2023","unstructured":"Oktem A, Rasulova G, Cavdarli B, Bostanci S, Heper A, Vural S. Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations. Clin Exp Dermatol. 2023;48(2):161\u20135. https:\/\/doi.org\/10.1093\/ced\/llac023.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1232_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/mrcr\/rxab008","volume":"6","author":"A Unal Enginar","year":"2022","unstructured":"Unal Enginar A, Gundogdu M. Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever. Mod Rheumatol Case Rep. 2022;6(1):19\u201321. https:\/\/doi.org\/10.1093\/mrcr\/rxab008.","journal-title":"Mod Rheumatol Case Rep"},{"key":"1232_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jdcr.2025.07.018","volume":"64","author":"C Akpala","year":"2025","unstructured":"Akpala C, Aghazadeh-Mohandesi N, Davis JM, Alavi A. NOD2-mediated immune dysregulation linking hidradenitis suppurativa and Yao syndrome: Insights from 2 cases. JAAD Case Rep. 2025;64:191\u20134. https:\/\/doi.org\/10.1016\/j.jdcr.2025.07.018.","journal-title":"JAAD Case Rep"},{"key":"1232_CR40","doi-asserted-by":"publisher","first-page":"883811","DOI":"10.3389\/fimmu.2022.883811","volume":"13","author":"P Guillem","year":"2022","unstructured":"Guillem P, Mintoff D, Kabbani M. Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases. Front Immunol. 2022;13:883811. https:\/\/doi.org\/10.3389\/fimmu.2022.883811.","journal-title":"Front Immunol"},{"issue":"5","key":"1232_CR41","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1111\/jdv.19706","volume":"38","author":"L Calabrese","year":"2024","unstructured":"Calabrese L, Vitale A, Moltrasio C. Hyper-IgD syndrome and hidradenitis suppurativa: An intriguing link. J Eur Acad Dermatol Venereol JEADV. 2024;38(5):e444\u20136. https:\/\/doi.org\/10.1111\/jdv.19706.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"2","key":"1232_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/sjmms.sjmms_464_24","volume":"13","author":"M Juraij","year":"2025","unstructured":"Juraij M, Barakat F, Ifthikar Z, Alsohaibani F. Hyperimmunoglobulinemia D Syndrome Masquerading as Familial Mediterranean Fever, Hidradenitis Suppurativa, and Crohn\u2019s Disease: A Case Report. Saudi J Med Med Sci. 2025;13(2):149\u201352. https:\/\/doi.org\/10.4103\/sjmms.sjmms_464_24.","journal-title":"Saudi J Med Med Sci"},{"issue":"2","key":"1232_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jaad.2024.07.1533","volume":"92","author":"S Miskinyte","year":"2025","unstructured":"Miskinyte S, Duchatelet S, Delage M. Clinical characteristics and genetic analysis of 14 patients affected with acne (A) fulminans and hidradenitis suppurativa (SH): ASH syndrome, a new phenotypic entity. J Am Acad Dermatol. 2025;92(2):332\u20134. https:\/\/doi.org\/10.1016\/j.jaad.2024.07.1533.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1232_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.clindermatol.2023.08.021","volume":"41","author":"JC BeataJastrz\u0105b,Szepietowski","year":"2023","unstructured":"BeataJastrz\u0105b,Szepietowski JC, Matusiak \u0141. Hidradenitis suppurativa and follicular occlusion syndrome: Where is the pathogenetic link? Clin Dermatol. 2023;41(5):576\u201383. https:\/\/doi.org\/10.1016\/j.clindermatol.2023.08.021.","journal-title":"Clin Dermatol"},{"issue":"11","key":"1232_CR45","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/exd.14919","volume":"32","author":"ASLE de Oliveira","year":"2023","unstructured":"de Oliveira ASLE, de Siqueira RC, Nait-Meddour C. A loss-of-function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa. Exp Dermatol. 2023;32(11):1935\u201345. https:\/\/doi.org\/10.1111\/exd.14919.","journal-title":"Exp Dermatol"},{"key":"1232_CR46","doi-asserted-by":"publisher","first-page":"1542909","DOI":"10.3389\/fmed.2025.1542909","volume":"12","author":"Q Song","year":"2025","unstructured":"Song Q, Zhang C, Xu P. PSENEN mutation in a Chinese family manifesting as concurrent hidradenitis suppurativa and Dowling-Degos disease: a case report of four generations. Front Med. 2025;12:1542909. https:\/\/doi.org\/10.3389\/fmed.2025.1542909.","journal-title":"Front Med"},{"key":"1232_CR47","doi-asserted-by":"publisher","unstructured":"Cortez Cardoso Penha R, Cortez de Almeida RF, C\u00e2mara Mariz J, Brewer Lisboa L, do Nascimento Barbosa L, Souto da Silva R. The deregulation of NOTCH pathway, inflammatory cytokines, and keratinization genes in two Dowling-Degos disease patients with hidradenitis suppurativa. Am J Med Genet A. 2020;182(11):2662\u20132665. https:\/\/doi.org\/10.1002\/ajmg.a.61800","DOI":"10.1002\/ajmg.a.61800"},{"issue":"5","key":"1232_CR48","first-page":"347","volume":"15","author":"L Maintz","year":"2005","unstructured":"Maintz L, Betz RC, Allam JP. Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol EJD. 2005;15(5):347\u201352.","journal-title":"Eur J Dermatol EJD"},{"issue":"3","key":"1232_CR49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.clindermatol.2013.11.006","volume":"32","author":"C Dessinioti","year":"2014","unstructured":"Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol. 2014;32(3):397\u2013408. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.11.006.","journal-title":"Clin Dermatol"},{"issue":"5","key":"1232_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/archderm.1981.01650050041019","volume":"117","author":"BA Skinner","year":"1981","unstructured":"Skinner BA, Greist MC, Norins AL. The keratitis, ichthyosis, and deafness (KID) syndrome. Arch Dermatol. 1981;117(5):285\u20139.","journal-title":"Arch Dermatol"},{"key":"1232_CR51","doi-asserted-by":"publisher","first-page":"llaf506","DOI":"10.1093\/ced\/llaf506","volume":"13","author":"E Molinelli","year":"2025","unstructured":"Molinelli E, Gioacchini H, De Simoni E. Hidradenitis suppurativa in chromosomal abnormalities, genodermatoses, and genetic disorders: a review. Clin Exp Dermatol Published online November. 2025;13:llaf506. https:\/\/doi.org\/10.1093\/ced\/llaf506.","journal-title":"Clin Exp Dermatol Published online November"},{"key":"1232_CR52","doi-asserted-by":"publisher","unstructured":"Ahmad A, Moore T, Ahmad A, Moore T. Anakinra in Pyogenic Arthritis, Acne, Pyoderma Gangrenosum, and Suppurative Hidradenitis (PAPASH) Spectrum Disorder: A Case Report and Literature Review. Cureus. 2024;16(6). https:\/\/doi.org\/10.7759\/cureus.62247.","DOI":"10.7759\/cureus.62247"},{"issue":"10","key":"1232_CR53","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/ijd.17796","volume":"64","author":"C Moltrasio","year":"2025","unstructured":"Moltrasio C, Romagnuolo M, Maronese CA, Carrabba M, Fabio G, Marzano AV. Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL-1 Blockade: A Case Report. Int J Dermatol. 2025;64(10):1923\u20135. https:\/\/doi.org\/10.1111\/ijd.17796.","journal-title":"Int J Dermatol"},{"issue":"3","key":"1232_CR54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/annrheumdis-2020-218870","volume":"80","author":"PJ Mease","year":"2021","unstructured":"Mease PJ, Lertratanakul A, Anderson JK. Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2. Ann Rheum Dis. 2021;80(3):312\u201320. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218870.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"1232_CR55","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","volume":"384","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Anderson JK, Magrey M. Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis. N Engl J Med. 2021;384(13):1227\u201339. https:\/\/doi.org\/10.1056\/NEJMoa2022516.","journal-title":"N Engl J Med"},{"issue":"16","key":"1232_CR56","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","volume":"377","author":"P Mease","year":"2017","unstructured":"Mease P, Hall S, FitzGerald O. Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis. N Engl J Med. 2017;377(16):1537\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1615975.","journal-title":"N Engl J Med"},{"issue":"10214","key":"1232_CR57","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Song IH, Pangan AL. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet. 2019;394(10214):2108\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(19)32534-6.","journal-title":"Lancet"},{"issue":"10349","key":"1232_CR58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(22)01212-0","volume":"400","author":"A Deodhar","year":"2022","unstructured":"Deodhar A, Van den Bosch F, Poddubnyy D. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2022;400(10349):369\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(22)01212-0.","journal-title":"Lancet"},{"issue":"4","key":"1232_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/medicina59040801","volume":"59","author":"F Martora","year":"2023","unstructured":"Martora F, Scalvenzi M, Ruggiero A, Potestio L, Battista T, Megna M. Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature. Med (Mex). 2023;59(4):801. https:\/\/doi.org\/10.3390\/medicina59040801.","journal-title":"Med (Mex)"},{"issue":"6","key":"1232_CR60","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaad.2025.01.057","volume":"92","author":"K Li","year":"2025","unstructured":"Li K, Peri K, Piguet V. Comparative analyses of hidradenitis suppurativa surgical methods: A systematic review and meta-analysis. J Am Acad Dermatol. 2025;92(6):1367\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2025.01.057.","journal-title":"J Am Acad Dermatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01232-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:45:58Z","timestamp":1786607158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01232-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01232-0","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AA serves as the board member of the Hidradenitis Suppurativa Foundation, received grants from the NIH, HSF, La Roche-Posay, serves as the chair of Independent Data Monitoring: InflaRX, Almirall, Zura Bio and a consultant for AbbVie, Almirall, Avalo, BI, Cantargia, InflaRx, Incyte, LEO Pharma, Sanofi, Navigator, Novartis and UCB Pharma. JYH, AL, CAM, AVM, JMD, VP have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25"}}